Recent advances in the treatment of systemic sclerosis associated interstitial lung disease

被引：4

作者：

Kamenova, Antoniya ^{[1
]}

Tzouvelekis, Argyris ^{[2
]}

Margaritopoulos, George A. ^{[1
]}

机构：

[1] London North West Univ Hosp HT, Interstitial Lung Dis Unit, London, England

[2] Univ Patras, Resp Med Dept, Patras, Greece

来源：

FRONTIERS IN MEDICINE | 2023年 / 10卷

关键词：

interstitial lung disease; systemic sclerosis; cyclophosphamide; rituximab; mycophenolate mofetil; tocilizumab; nintedanib; pirfenidone; IDIOPATHIC PULMONARY-FIBROSIS; CIGARETTE-SMOKING; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; TELOMERE LENGTH; PHASE-II; SCLERODERMA; SURVIVAL; CYCLOPHOSPHAMIDE; THERAPY;

D O I：

10.3389/fmed.2023.1155771

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory disorders. The development of connective tissue disease-associated interstitial lung disease (CTD-ILD) is a key complication associated with significant morbidity and mortality. The aim of this review is to explore the pathogenesis of CTD-ILD and summarize the recent evidence from clinical trials for novel treatment options, including the role of antifibrotics and immunomodulatory therapies with a focus on systemic sclerosis associated ILD. Further clinical trials are ongoing to explore combination therapies and more targeted therapeutic options. Clinicians remain faced with the difficult challenge of appropriately selecting patients who will benefit from the available therapies and timing the start of therapy at the most suitable part of the disease course.

引用

页数：9

共 82 条

[1] EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY [J].

Allanore, Y. ;

Wung, P. ;

Soubrane, C. ;

Esperet, C. ;

Frederic, M. ;

Bejuit, R. ;

Lahmar, A. ;

Khanna, D. ;

Denton, C. .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :157-158

[2] Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON [J].

Allanore, Yannick ;

Vonk, Madelon C. ;

Distler, Oliver ;

Azuma, Arata ;

Mayes, Maureen D. ;

Gahlemann, Martina ;

James, Alexandra ;

Kohlbrenner, Veronika ;

Alves, Margarida ;

Khanna, Dinesh ;

Highland, Kristin B. .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) :1722-1729

[3] Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension [J].

Antoniou, K. M. ;

Margaritopoulos, G. A. ;

Goh, N. S. ;

Karagiannis, K. ;

Desai, S. R. ;

Nicholson, A. G. ;

Siafakas, N. M. ;

Coghlan, J. G. ;

Denton, C. P. ;

Hansell, D. M. ;

Wells, A. U. .

ARTHRITIS & RHEUMATOLOGY, 2016, 68 (04) :1004-1012

[4] A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis [J].

Bossini-Castillo, Lara ;

Simeon, Carmen P. ;

Beretta, Lorenzo ;

Broen, Jasper C. ;

Vonk, Madelon C. ;

Rios-Fernandez, Raquel ;

Espinosa, Gerard ;

Carreira, Patricia ;

Camps, Maria T. ;

Castillo, Maria J. ;

Gonzalez-Gay, Miguel A. ;

Beltran, Emma ;

Freire, Maria del Carmen ;

Narvaez, Javier ;

Tolosa, Carlos ;

Witte, Torsten ;

Kreuter, Alexander ;

Schuerwegh, Annemie J. ;

Hoffmann-Vold, Anna-Maria ;

Hesselstrand, Roger ;

Lunardi, Claudio ;

van Laar, Jacob M. ;

Chee, Meng May ;

Herrick, Ariane ;

Koeleman, Bobby P. C. ;

Denton, Christopher P. ;

Fonseca, Carmen ;

Radstake, Timothy R. D. J. ;

Martin, Javier .

ARTHRITIS RESEARCH & THERAPY, 2012, 14 (02)

[5] Incidence and prevalence of systemic sclerosis: A systematic literature review [J].

Chifflot, Helene ;

Fautrel, Bruno ;

Sordet, Christelle ;

Chatelus, Emmanuel ;

Sibilia, Jean .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (04) :223-235

[6] Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: Results from the Iowa women's health study [J].

Criswell, LA ;

Merlino, LA ;

Cerhan, JR ;

Mikuls, TR ;

Mudano, AS ;

Burma, M ;

Folsom, AR ;

Saag, KG .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (06) :465-471

[7] Association between telomere length and survival in patients with idiopathic pulmonary fibrosis [J].

Dai, Jinghong ;

Cai, Hourong ;

Li, Hui ;

Zhuang, Yi ;

Min, Haiyan ;

Wen, Yanting ;

Yang, Jie ;

Gao, Qian ;

Shi, Yi ;

Yi, Long .

RESPIROLOGY, 2015, 20 (06) :947-952

[8] Clinical pharmacokinetics of cyclophosphamide [J].

de Jonge, ME ;

Huitema, ADR ;

Rodenhuis, S ;

Beijnen, JH .

CLINICAL PHARMACOKINETICS, 2005, 44 (11) :1135-1164

[9] Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis [J].

De Lauretis, Angelo ;

Sestini, Piersante ;

Pantelidis, Panagiotis ;

Hoyles, Rachel ;

Hansell, David M. ;

Goh, Nicole S. L. ;

Zappala, Christopher J. ;

Visca, Dina ;

Maher, Toby M. ;

Denton, Christopher P. ;

Ong, Voon H. ;

Abraham, David J. ;

Kelleher, Peter ;

Hector, Laureen ;

Wells, Athol U. ;

Renzoni, Elisabetta A. .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (04) :435-446

[10] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease [J].

Distler, Oliver ;

Highland, Kristin B. ;

Gahlemann, Martina ;

Azuma, Arata ;

Fischer, Aryeh ;

Mayes, Maureen D. ;

Raghu, Ganesh ;

Sauter, Wiebke ;

Girard, Mannaig ;

Alves, Margarida ;

Clerisme-Beaty, Emmanuelle ;

Stowasser, Susanne ;

Tetzlaff, Kay ;

Kuwana, Masataka ;

Maher, Toby M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26) :2518-2528

← 1 2 3 4 5 6 7 8 9 →